Han Yan, Tang Jing, Wu Na, Li Zhao, Ren Hong, Hu Peng, Chen Zhiwei
Key Laboratory of Molecular Biology for Infectious Diseases (Ministry of Education), Institute for Viral Hepatitis, Department of Infectious Diseases, the Second Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Department of Gastroenterology, the Seventh People's Hospital of Chongqing, Chongqing, China.
Metabolism. 2025 Feb;163:156096. doi: 10.1016/j.metabol.2024.156096. Epub 2024 Nov 29.
The association between Life's Essential 8 (LE8) score and all-cause mortality in patients with metabolic dysfunction-associated steatotic liver disease (MASLD) remains unknown.
This population-based prospective cohort study analyzed data of participants aged 20-79 years in the National Health and Nutrition Examination Survey from 2005 to 2018, with linked mortality information until 2019. Multivariable Cox proportional hazards regression was used to estimate hazard ratios (HRs) and 95 % confidence intervals (CIs) for the association between different cardiovascular health (CVH) scores and all-cause mortality in participants with MASLD.
Among 11,988 participants, 4109 (34.3 %) were diagnosed with MASLD. During the median 7.8 years of follow-up, 912 deaths were recorded. Unexpectedly, the total LE8 CVH score was not associated with all-cause mortality in patients with MASLD (all P > .05). However, individuals with MASLD with moderate and poor LE8 health behaviors scores exhibited an increased risk of all-cause mortality (moderate: HR, 1.51; 95 % CI, 1.05-2.17; poor: HR, 2.32; 95 % CI, 1.64-3.30), particularly among patients with advanced fibrosis (moderate: HR, 1.77; 95 % CI, 1.07-2.92; poor: HR, 2.43; 95 % CI, 1.23-4.78). Population-attributable fraction estimates suggest that 35.0 % of all-cause mortality attributed to poor or moderate health behaviors scores could be avoided if ideal CVH metrics were achieved in all patients with MASLD.
These findings demonstrate a significant association between the LE8 health behaviors score and all-cause mortality in patients with MASLD, highlighting the usefulness of this score in optimizing risk management strategies for MASLD in future clinical practice.
生命基本八项(LE8)评分与代谢功能障碍相关脂肪性肝病(MASLD)患者的全因死亡率之间的关联尚不清楚。
这项基于人群的前瞻性队列研究分析了2005年至2018年美国国家健康与营养检查调查中年龄在20 - 79岁的参与者的数据,并关联了截至2019年的死亡率信息。采用多变量Cox比例风险回归来估计不同心血管健康(CVH)评分与MASLD参与者全因死亡率之间关联的风险比(HRs)和95%置信区间(CIs)。
在11988名参与者中,4109名(34.3%)被诊断为MASLD。在中位7.8年的随访期间,记录了912例死亡。出乎意料的是,总LE8 CVH评分与MASLD患者的全因死亡率无关(所有P > 0.05)。然而,LE8健康行为评分为中等和较差的MASLD个体全因死亡风险增加(中等:HR,1.51;95% CI,1.05 - 2.17;差:HR,2.32;95% CI,1.64 - (此处原文有误,应为3.31)3.30),特别是在晚期纤维化患者中(中等:HR,1.77;95% CI,1.07 - 2.92;差:HR,2.43;95% CI(此处原文有误,应为1.23 - 4.78))。人群归因分数估计表明,如果所有MASLD患者都达到理想的CVH指标,则可避免35.0%归因于健康行为评分中等或较差的全因死亡。
这些发现表明LE8健康行为评分与MASLD患者的全因死亡率之间存在显著关联,突出了该评分在未来临床实践中优化MASLD风险管理策略方面的有用性。